Broadpoint Upgrades Verenium (VRNM) to Buy
Broadpoint Capital upgrades Verenium (Nasdaq: VRNM) from Neutral to Buy.
Verenium Corporation, together with its subsidiaries, engages in the development and production of specialty enzyme products, and production and commercialization of biofuels.
Related Categories
UpgradesStocks Mentioned
Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
